REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

PlexBio Co., Ltd. (Taiwan, China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: PlexBio Co., Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

PlexBio Co., Ltd. designs, develops and manufactures IVD products and instrumentations. The company was founded in 2009 and is headquartered in Taipei, Taiwan.

Headquarters
6F-1,No.351, Yangguang St, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the PlexBio Co., Ltd. report to view the information.

Website: http://www.plexbio.com

Basic Information
Total Employees:
Purchase the PlexBio Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the PlexBio Co., Ltd. report to view the information.
Financial Auditors:
Purchase the PlexBio Co., Ltd. report to view the information.
Incorporation Date:
December 17, 2009
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
34.84%
Purchase this report to view the information.
11.81%
Purchase this report to view the information.
4.09%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Plexbio Hongkong Co.,Limited (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after PlexBio Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-65.63%▼
Total operating revenue
-65.19%▼
Operating profit (EBIT)
-47.55%▼
EBITDA
-96.23%▼
Net Profit (Loss) for the Period
-33.26%▼
Total assets
10.58%▲
Total equity
-14.45%▼
Operating Profit Margin (ROS)
-119.46%▼
Net Profit Margin
-90.81%▼
Return on Equity (ROE)
-3.8%▼
Quick Ratio
-6.43%▼
Cash Ratio
0.83%▲

Similar companies

Syngen Biotech Co., Ltd.
 
DV Biomed Co., Ltd.
CH Biotech R&D Co., Ltd.
 
Medigen Biotechnology Corporation
EirGenix Inc.
 
Glac Biotech Co., Ltd. (Tainan City) (丰华生物科技 (台南市))
ASLAN Pharmaceuticals Limited
 
Terawins, Inc.
Tanvex BioPharma, Inc.
 
Taiwan Leader Biotech Corp. (Taipei City) (台湾利得生物科技股份有限公司 (台北市))
Vectorite Biomedical Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo